The RIQAS Epstein Barr Virus EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.

  • Liquid ready-to-use
  • 100% human plasma
  • Quarterly reporting (3 samples per quarterly distribution)
  • Submit results and view reports online via RIQASNet
  • Suitable for both quantitative and qualitative methods of analysis

Parameters

  • Anti-EBNA IgG
  • Anti-EBV VCA IgG
  • Anti-EBV VCA IgM
DescriptionSizeCatalogue #
RIQAS Serology (Epstein Barr Virus) Programme 3 x 1 ml RQ9153